T. Rowe Price Associates’s Kyverna Therapeutics KYTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.62M Buy
2025
Q1
$1.12M Sell
2024
Q4
$2.22M Sell
2024
Q3
$3.07M Sell
2024
Q2
$5.02M Sell
2024
Q1
$23.1M Buy